Regeneron Pharmaceuticals Inc. (REGN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Regeneron Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$813.27
−0.35% today
Market cap
$84.0B
Overall quality
—
Kronos AI 30-day
−9.4%
0 of 8 simulated paths end higher
Regeneron Pharmaceuticals Inc. (REGN) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $84.0B. It trades at $813.27, down 0.35% today. 23 analysts' average target of $866.00 implies +6.5% from today's price. Kronos AI's 30-day forecast is −9.4% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $866.00 |
| Low – high | $740.00 – $1,030.00 |
| Analysts | 23 |
| Upside to average | +6.5% |
Kronos AI 30-day forecast
| Expected close | $739.09 (−9.4%) |
| Likely range | −13.8% … −7.3% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.